Podcasts about canadian institute

The Famine of 1932–1933 in Ukraine: An Anatomy of the Holodomor (CIUS Press, 2018) is a distillation of thirty years of study of the topic by one of Ukraine's leading historians. In this account, Stanislav Kulchytsky ably incorporates a vast array of sources and literature that have become available in the past three decades into a highly readable narrative, explaining the motives, circumstances and course of this terrible crime against humanity. As the author shows, the Holodomor was triggered by the Bolshevik effort to build a communist socioeconomic order in the Soviet Union. For the peasant majority of the population, this meant the forcible collectivization of individual farms, the seizure of livestock and farm implements, and the conversion of independent farmers into agricultural laborers. Excessive requisitioning of grain and other foodstuffs in the collectivization drive led to famine and deaths in grain-producing regions of the USSR by early 1932. In Ukraine, punitive measures authorized by the Kremlin's top leadership greatly worsened the famine in late 1932 and turned it into the Holodomor, which claimed more than three million lives in the first half of 1933. Identifying key events and decisions that produced the Holodomor, Kulchytsky analyzes economic and political factors, including the national dimension in Ukraine. The book begins with the author's address to the reader, presenting his view of the Holodomor as genocide. In addition to the main text, the volume includes a preface, afterword, glossary, list of abbreviations and acronyms, bibliography, and a short essay on the author and his writings. The Famine of 1932-1933 in Ukraine: An Anatomy of the Holodomor was prepared for publication by the Holodomor Research and Education Consortium (HREC) of the Canadian Institute of Ukrainian Studies, Faculty of Arts, University of Alberta. HREC undertook the translation of Stanislav Kulchytsky's monograph Ukraïns'kyi holodomor v konteksti polityky Kremlia pochatku 1930 rr. as part of its efforts to make available in English seminal works by Ukrainian scholars of the Holodomor. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

The Famine of 1932–1933 in Ukraine: An Anatomy of the Holodomor (CIUS Press, 2018) is a distillation of thirty years of study of the topic by one of Ukraine's leading historians. In this account, Stanislav Kulchytsky ably incorporates a vast array of sources and literature that have become available in the past three decades into a highly readable narrative, explaining the motives, circumstances and course of this terrible crime against humanity. As the author shows, the Holodomor was triggered by the Bolshevik effort to build a communist socioeconomic order in the Soviet Union. For the peasant majority of the population, this meant the forcible collectivization of individual farms, the seizure of livestock and farm implements, and the conversion of independent farmers into agricultural laborers. Excessive requisitioning of grain and other foodstuffs in the collectivization drive led to famine and deaths in grain-producing regions of the USSR by early 1932. In Ukraine, punitive measures authorized by the Kremlin's top leadership greatly worsened the famine in late 1932 and turned it into the Holodomor, which claimed more than three million lives in the first half of 1933. Identifying key events and decisions that produced the Holodomor, Kulchytsky analyzes economic and political factors, including the national dimension in Ukraine. The book begins with the author's address to the reader, presenting his view of the Holodomor as genocide. In addition to the main text, the volume includes a preface, afterword, glossary, list of abbreviations and acronyms, bibliography, and a short essay on the author and his writings. The Famine of 1932-1933 in Ukraine: An Anatomy of the Holodomor was prepared for publication by the Holodomor Research and Education Consortium (HREC) of the Canadian Institute of Ukrainian Studies, Faculty of Arts, University of Alberta. HREC undertook the translation of Stanislav Kulchytsky's monograph Ukraïns'kyi holodomor v konteksti polityky Kremlia pochatku 1930 rr. as part of its efforts to make available in English seminal works by Ukrainian scholars of the Holodomor. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/genocide-studies

Dr. Sumanta (Monty) Pal and Dr. Arielle Elkrief discuss the clinical relevance of the gut microbiome in cancer immunotherapy and the importance of antibiotic stewardship, as well as interventions currently being explored to treat gut dysbiosis and optimize immunotherapy response. TRANSCRIPT Dr. Sumanta (Monty) Pal: Hi everyone, I'm Dr. Monty Pal, welcoming you to the ASCO Daily News Podcast. I'm a medical oncologist. I'm a professor and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles.  Today we're here to discuss one of my favorite topics, which is the gut microbiome. It's almost hard to avoid the gut microbiome nowadays if you look at medical literature within oncology. It's an emerging phenomenon, but there are a couple of individuals that I would really define as pioneers in the field. And one of them is actually with me today, Dr. Arielle Elkrief, to discuss the clinical relevance of the gut microbiome, particularly amongst patients receiving immunotherapy, although I imagine our conversation today will take many twists and turns. Arielle is an assistant professor and clinician scientist in the Department of Oncology at the University of Montreal, and she is co-director of the CHUM Microbiome Center there.  FYI for the listeners, we have our full disclosures in the transcript of this episode.  Arielle, thank you so much for joining us today. Dr. Arielle Elkrief: Thanks so much, Monty. This is going to be amazing. Dr. Sumanta (Monty) Pal: Well, I have to tell you what sort of inspired me to bring you on as a guest. It was one of many things, but it was this really terrific ASCO Educational [Book] article that you wrote. Now, I have to tell you, I've read all the articles sort of cover to cover in the book, and they're always a wonderful primer, so if our audience is studying for board research or something of that sort, it's a terrific resource to go through. I have to tell you, this piece on the gut microbiome that you wrote is nothing short of a masterpiece. If you read this cover to cover, it's actually going to give you, I think, a sense of the current state and future state of the field. I wanted to start by just sort of beginning with sort of the origin story for a lot of this, which is this association between the gut microbiome and immunotherapy response. This takes us back several years to this pivotal series of papers in Science. Maybe you could walk our audience through that. Dr. Arielle Elkrief: Absolutely. Well, thank you so much for your kind words about the ASCO [Educational] Book. It was a team effort with a lot of key opinion leaders in the field, so I'm really glad to learn that you've liked it.  Moving backwards in terms of how we came to understand that the gut microbiome is essential to priming a response to cancer immunotherapy actually goes back to 2015 and seminal papers that looked at what happens when we take mice that are germ-free mice that have never been exposed to a microbiome. These are mice that are born by cesarean section and essentially live in a bubble. And when we give those mice tumors and treat them, in the first papers with anti-CTLA-4 treatment, we realized that these antibodies don't work at all. And that was the first observation that the presence of a gut microbiome was essential to mounting an anti-cancer immune response. When we supplemented those same mice with beneficial bacteria or feces from responder patients, we were able to restore the response to immunotherapy. And so those were really the first preclinical observations that made us understand the critical role of the microbiome in immunotherapy response. Moving a little bit in the future, we examined the fecal microbiome composition using shotgun metagenomic sequencing in different cohorts of patients with solid tumors, namely lung cancers, kidney cancers, and also skin tumors like melanoma, and found that patients who responded to immunotherapy had a distinct microbiome that was characterized by beneficial bacteria compared to patients who experienced resistance to immunotherapy that had a dysbiotic or diseased microbiome. Dr. Sumanta (Monty) Pal: So, you know, it's interesting, these techniques that we're using to sequence the gut, they're a little bit different. So I wonder if you can give the audience a quick primer on these techniques that you're so well versed in, shotgun metagenomic sequencing, 16S rRNA sequencing. If you had to describe this in 30 seconds, which is a tall task, how would you do that? Dr. Arielle Elkrief: That's a tall task. Much of what we know about the microbiome initially came from a technique called 16S rRNA sequencing. This is a technique that amplifies the 16S region and basically tells you at the genus level what's going on at the level of bacterial composition. This technique is fast, relatively cheap, and can be performed on a laptop computer, which is excellent. The problem is that it's prone to a lot of technical variations. Different primers might give you different results, and you're really limited at the genus resolution. You can't get a good resolution in terms of species, and we're learning that different species from the same genus might have different physiological properties, and the same thing goes at the strain level. So when we really zone in and look at inter-species changes, we're seeing that these actually have specific functions in the host. So that brings us to metagenomic sequencing, which is a whole genome sequencing, next-generation sequencing based method that looks at the whole composition and gives you information not only on bacteria, but you might also get fungal and viral properties. You can zoom in on the strain level. You can also get functional output, so we can examine what the metabolic properties of specific species or strains might look like. The negative aspects of shotgun metagenomic sequencing is that it takes a lot of computational power in order to analyze the results and it might take a little bit longer. And certainly, within the clinical setting, not something that's feasible yet.  And that brings us to more novel point-of-care biomarker tools that we've collaborated in developing along with Dr. Laurence Zitvogel and Dr. Lisa Derosa at Gustave Roussy, that learning from the shotgun metagenomics results designed a probe using quantitative PCR which looks for this specific bacteria we know to be important and developed a ratio of harmful bacteria to beneficial bacteria. This is called the TOPOSCORE, and it actually is able to predict quite nicely the response to immunotherapy using a stool sample and a really good turnaround time of almost 72 hours. Dr. Sumanta (Monty) Pal: That was a perfect overview and a lot of information in a short amount of time. It also makes you take out your high school biology textbooks, doesn't it, to understand that the bacterial ribosome, right, is a different size and shape, and that's what we're sequencing here. But these techniques I think are incredibly important, and I'm glad you actually discussed this, this RT-PCR based strategy of calculating the TOPOSCORE. It lends itself to this phenomenon of dysbiosis, and I think for our audience, that's going to be an important term to understand as time goes on. There's the normal healthy gut and then there's this phenomenon of dysbiosis, which is, I guess, simply put, an unhealthy gut. But tell us about, you know, how often you see dysbiosis in a cancer patient, maybe versus a normal healthy adult. Dr. Arielle Elkrief: So, I think we can split up your question into two parts. One is we know from cohort studies and population level-based studies that the microbiome of patients with cancer is distinct from healthy patients or healthy people. And we know that because of the global composition. We also think that there are diversity metrics that lend themselves to being described as dysbiotic. But we do know that the microbiome of people with cancer is distinct from healthy volunteers. That's the first point.  In terms of how frequently dysbiosis occurs in patients with cancer, it's not very well defined. We know that even among healthy people, there is a certain level of dysbiosis. Laurence in her talk mentioned that to be about 10% to 20%. And the other fascinating component is that when we're thinking about dysbiosis and the cancer associated microbiome, in terms of the species that are enriched, it's quite striking that a lot of these dysbiotic or negative bacteria are also found to be enriched in patients with metabolic disease, like cardiovascular disease, for example. And so it's unclear if dysbiosis is the cause or consequence, but there definitely seems to be a general pattern of disease when looking at the microbiome compared to healthy people. Dr. Sumanta (Monty) Pal: That's interesting. So, I'll tell you, my second favorite portion of your article, and I'll tell you my favorite portion as well in the context of this podcast, but my second favorite part was the section around antibiotic stewardship. You know, the utilization of antibiotics in a very pragmatic fashion amongst our patients. Can you describe why that's so critical in the context of the microbiome? Dr. Arielle Elkrief: Antibiotics can disrupt the gut microbiome composition. We know this from mouse studies, but also cohort studies of patients that are exposed to antibiotics. And most importantly, we know that patients who are exposed to antibiotics, either before or during the immunotherapy period, have significantly worse progression-free survival and overall survival to immunotherapy. And this is true for immunotherapy in the monotherapy setting, but also when combined with chemotherapy. What's striking is that when we look at patients who are just treated with chemotherapy, we don't see the negative outcome of antibiotics on outcome and progression-free survival and overall survival, suggesting that the negative impact of antibiotics on outcomes is really specific to immunotherapy backbones. The other important point is that this negative signal is maintained even after adjusting for standard prognostic variables in the specific malignancies that we're looking at. And then most importantly, at the mechanistic level, we were able to actually pinpoint the mechanism behind this antibiotic related dysbiosis. And we see this with a bloom of negative bacteria which induces a loss of MAd-CAM, which is an endothelial gut checkpoint immune marker, and that causes an efflux of immunosuppressive T cells, which are usually in the gut, to go straight into the tumor where they make the tumor unamenable to an immunotherapy response. And so now we finally have the mechanism as to why antibiotics are harmful and why we need to practice antibiotic stewardship. Dr. Sumanta (Monty) Pal: And just to be clear for the audience, I mean, if a patient needs antibiotics, they need antibiotics. But perhaps it just suggests that, and we have, I suppose, this predilection as oncologists, just for the minor cold or cough or what have you, we maybe should be a little bit more cognizant of whether or not antibiotics are truly necessary. Is that fair? Dr. Arielle Elkrief: Absolutely. So what we're advocating for is antibiotic stewardship, and this is the clear recommendation that we can make. So that means confirming a bacterial infection. If it's there and antibiotics are indicated, to choose the most narrow spectrum for the shortest course and constantly re-evaluate the indication of antibiotics. And of course, we need to work with our colleagues in infectious diseases who've done incredible work in antibiotic stewardship. And all along this process we also need to be mindful of other medications and polypharmacy, such as proton pump inhibitors or narcotics, for example, we think that these other medications which are frequently prescribed in our cancer population can also potentially have negative impacts on the microbiome and immunotherapy response. Dr. Sumanta (Monty) Pal: I think that's a terrific summary and big guidance for the audience.  I promised you I'd tell you my favorite part of your article, and this is this huge table. I think the table is two and a half pages long, if I remember correctly, but it's an awesome table, and I highly recommend our audience to check this out. It lists literally every therapeutic trial for the microbiome under the sun. And so it begins with the approach of fecal microbiota transplant, which I'm going to ask you to tell us about in a second, but it also hinges on a lot of really cool sort of novel therapies, live bacterial products, mixes of different microbial products. Maybe take us through this whole approach of FMT (fecal microbiota transplantation). I actually wasn't aware of the dozens of trials that you listed there in this space. It seems like it's a very active area of research. Dr. Arielle Elkrief: Definitely. So, as you alluded to, FMT or fecal microbiota transplantation is the most well studied and direct way to modify the patient's microbiome. This technique aims to replace the patient's dysbiotic microbiome with that of a healthy microbiome, either from a healthy donor volunteer that's been heavily screened, or from a patient who experienced response to immunotherapy. And, as three landmark studies so far that have been published demonstrated the potential of FMT to reduce primary resistance or secondary resistance to immunotherapy, and this has been in melanoma.  We also recently reported on the results of our FMT-LUMINate trial, which looked at patients with lung cancer and melanoma. Once again, FMT, when combined with immunotherapy was safe and led to a higher proportion of responses than we would normally expect.  We're now also looking at randomized trials that have come out. So the first being the TACITO trial in kidney cancer, which compared FMT plus pembrolizumab and axitinib to placebo in patients with RCC, and again, FMT was safe and feasible and also led to an increased progression-free survival at one year, meeting the study's primary endpoint.  And so, so far, there's a wealth of data really showing the promise of FMT when combined with immunotherapy, and we're now in the process of conducting larger randomized trials, including in melanoma with the CCTG (Canada Cancer Trials Group) in our ME17 or Canbiome2 trial, where we're going to be enrolling 128 patients with metastatic melanoma to receive FMT and standard of care immunotherapy compared to standard of care immunotherapy alone. Dr. Sumanta (Monty) Pal: You're very humble, so I've got to highlight for our audience. This was a mega grant that Arielle received to fund really the largest prospective exploration of FMT that will exist to date. So I'm really excited about that. I wish this was something we could participate in stateside.  Before we jump into the other approach, which is live bacterial products and mixes thereof, where do you see FMT going? I think that one of the perceived challenges with FMT is that it's hard to implement, right? You need to have a really robust framework when it comes to gastroenterology, the preparation's challenging. Is there a way to envision FMT use being more generalized? Dr. Arielle Elkrief: Those are great questions. So we're lucky in Canada to work with pioneers in FMT, Michael Silverman, Saman Maleki, and John Lenehan in London, Ontario, who had this really robust FMT healthy donor screening program, which literally screens for every pathogen under the sun, and we haven't had any problems with feasibility or implementing FMT in Canada. But I think that once we're going to hopefully start doing larger scale, randomized phase three studies, that we might run into problems with scalability. And I think also with regards to reproducibility, and that's the feedback that we're getting from some regulatory authorities, especially at the level of the FDA, where there are some concerns around inter- and intra-donor variability because, of course, we can't guarantee that every fecal sample is going to be the same. So that has really pushed the field to think about other strategies, such as live biotherapeutic products which take modified FMT or bacteria from stools from either healthy donors or from responder patients and basically turn them into drugs that are regulated as drugs and can then be studied in the context of investigational new drugs or products. Dr. Sumanta (Monty) Pal: I like this and, you know, I do think that there's a future for it. We just have to kind of put our heads together and figure out how to get over all of these logistical hurdles, but, you know, I agree, I think your group and others have demonstrated, especially with this trial that you're fanning out all throughout Canada, that it can potentially be done.  This is a topic that could probably go on for another couple of hours, right, especially based on the size of the table that you put together in this brilliant article, but tell us about live bacterial products or LBPs, as we call them these days. What's the current status, what's the future there? And maybe I'll give you less than two minutes here, although again, I realize it's a two-hour topic. Dr. Arielle Elkrief: You're probably better suited to speak about that because you've been one of the pioneers in terms of this. So we can think about LBPs in terms of single strain organisms, like CBM588 for an example, which your group did some amazing work in showing that, in a randomized setting, that this led to better responses than we would expect compared to just work with controls. We also know that LBPs can have multiple strains, up to 30. We're collaborating with a company called Cannabis Bioscience that is actually working on much larger communities of consortia. And so we're really excited about the direction that that's taking in terms of taking these LBPs and developing them from the drug perspective. In addition to LBPs, we know that there are other ways that we can change the microbiome, notably prebiotics, which are compounds which can have a beneficial impact on the microbiome. And one of these is camu camu, which I know your group is leading a clinical trial looking at camu camu and kidney cancer, and we're excited to see how that compares to FMT or LBPs, because that might be a potentially scalable alternative. Dr. Sumanta (Monty) Pal: That's awesome. What a terrific overview, and that was less than two minutes. I don't know how you did it. That's terrific.  Arielle, this has been such an insightful conversation. I just want to thank you for, again, a terrific article in the ASCO Educational Book. I highly recommend all of our listeners to go there and check it out, and also for sharing all these terrific insights on the podcast today. Dr. Arielle Elkrief: Thank you so much, Monty. Dr. Sumanta (Monty) Pal: And thanks to our listeners, too. If you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Thanks, everyone. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:    Dr. Sumanta (Monty) Pal  @montypal Dr. Arielle Elkrief Follow ASCO on social media:     @ASCO on Twitter    ASCO on Bluesky   ASCO on Facebook     ASCO on LinkedIn     Disclosures:    Dr. Sumanta (Monty) Pal:   Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview  Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical  Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis  Dr. Arielle Elkrief: Honoraria: AstraZenica, Bristol-Myers Squibb, Merck, EMD Serono Consulting or Advisory Role: Bristol-Myers Squibb Research Funding (Inst.): Kanvas Bioscience, AstraZeneca, Merck Other Relationship: Royal College of Surgeons and Physicians of Canada, Cedar's Cancer Center (Henry R. Shibata Fellowship), Canadian Institutes of Health Research (CIHR)

This episode of the Amazing Cities and Towns Podcast, Jim Hunt interviews Chelsey Jersak, Founder of Situate   ·       A candid conversation about urban planning and and, much more   7 Steps to an Amazing City:   Attitude Motivation Attention to Detail Zing Inclusiveness Neighborhood Empowerment Green Awareness   Thanks for listening and look forward to having you join us for the next episode.   Links Mentions During Show:  https://situateinc.ca/ ·       www.AmazingCities.org ·       www.AmazingCities.org/podcast to be a guest on the podcast   About   Chelsey Jersak is the founder and principal of Situate, an urban planning consulting firm in Edmonton offering rezoning, permitting, subdivision and strategic advisory services for infill projects across the city. Chelsey became familiar with IDEA soon after the organization formed, back when she was a city planner with the City of Edmonton. After moving to the private sector and starting Situate, Chelsey enthusiastically joined the IDEA board and has since filled many roles, including chairing the community relations and policy subcommittees, and serving as vice president, president and now past president.  Chelsey's area of focus on the board is strategy; she supports the organization in scaling up its oomph and impact through regular strategic planning sessions and tangible objectives and key results. She's also passionate about connecting the dots between urban redevelopment, climate action, and social wellbeing. Chelsey holds a Bachelor's degree in Regional and Urban Development and a Master's degree in Human Geography. She is a Registered Professional Planner and a member of the Canadian Institute of Planners. Her hobbies include downhill skiing and partner dancing, particularly an obscure Brazilian dance called Zouk. She also has an insatiable love for dill pickles.    About Your Host, Jim Hunt: Welcome to the “Building Amazing Cities and Towns Podcast” … The podcast for Mayors, Council Members, Managers, Staff and anyone who is interested in building an Amazing City.   Your host is Jim Hunt, the author of “Bottom Line Green, How American Cities are Saving the Planet and Money Too” and his latest book, “The Amazing City - 7 Steps to Creating an Amazing City”   Jim is also the former President of the National League of Cities, 27 year Mayor, Council Member and 2006 Municipal Leader of the Year by American City and County Magazine.   Today, Jim speaks to 1000's of local government officials each year in the US and abroad.   Jim also consults with businesses that are bringing technology and innovation to local government.   Amazing City Resources:   Buy Jim's Popular Books: ·       The Entrepreneurial City: Building Smarter Governments through Entrepreneurial Thinking:   https://www.amazingcities.org/copy-of-the-amazing-city   ·       The Amazing City: 7 Steps to Creating an Amazing City:   https://www.amazingcities.org/product-page/the-amazing-city-7-steps-to-creating-an-amazing-city   ·       Bottom Line Green: How America's Cities and Saving the Planet (And Money Too)  https://www.amazingcities.org/product-page/bottom-line-green-how-america-s-cities-are-saving-the-planet-and-money-too   FREE White Paper: ·       “10 Steps to Revitalize Your Downtown”  www.AmazingCities.org/10-Steps   Hire Jim to Speak at Your Next Event: ·       Tell us about your event and see if dates are available at www.AmazingCities.org/Speaking   Hire Jim to Consult with Your City or Town: ·       Discover more details at https://www.amazingcities.org/consulting   Discuss Your Business Opportunity/Product to Help Amazing Cities: ·       Complete the form at https://www.amazingcities.org/business-development   A Special Thanks to Bearing Advisors for the support of this podcast:  www.BearingAdvisors.Net      

What if the sudden mood changes, crushing fatigue, or unexpected anxiety you're experiencing aren't just stress or part of getting older, but signs of depression linked to perimenopause? In this episode, ADAA member expert and psychiatrist Dr. Crystal Clark joins host Gabe Howard to shine a light on one of the most overlooked mental health issues affecting women: the biological storm of perimenopause and its deep connection to depression and anxiety. They break down why up to 40% of women experience depression during this hormonal transition — and why so many are told to just “tough it out.”You'll learn the early warning signs to watch for, the science behind hormonal shifts and mental health, and why dismissing symptoms as “normal aging” could be harmful. Plus, they explore how therapy, medication, lifestyle shifts, and even hormone therapy can play a role in recovery. Whether you're in perimenopause, supporting someone who is, or just want to understand this life stage, this episode delivers clarity, compassion, and concrete takeaways. This episode has been sponsored by the Anxiety and Depression Association of America (ADAA). Our guest, Dr. Crystal Clark, is an internationally recognized psychiatrist in women's mental health. She holds a Canada Research Chair in Reproductive Mental Health. She is an Associate Professor in the Department of Psychiatry at the University of Toronto, and the Associate Head of Research at Women's College Hospital. Dr. Clark specializes in mood and anxiety disorders specifically across the reproductive life span (from menstruation to peri and post menopause). Dr. Clark's research has focused on psychopharmacology for the treatment of perinatal mood disorders.  Her research aims to prevent the recurrence of illness during pregnancy and postpartum through safe dose optimization and personalized dosing strategies. Her research also aims to develop identification and prevention strategies for all persons with perinatal mood and anxiety disorders including those who are disproportionately impacted by these disorders. Dr. Clark's research has been funded by the Canadian Institute of Health Research and the National Institutes of Health.  Among Dr. Clark's many leadership roles, she is a past president of the Marcé of North America, an organization dedicated to advancing perinatal mental health care, and she serves on the board of directors of Marcé International. She has been a contributor to large initiatives in Canada and the US to improve perinatal mental health in North America. As a thought leader, Dr. Clark is a thought leader and has been a contributor by several media outlets including CBS, NPR, NY Times, and Chicago Tonight regarding issues related to perinatal mental health. Our host, Gabe Howard, is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. Gabe is also the host of the "Inside Bipolar" podcast with Dr. Nicole Washington. Gabe makes his home in the suburbs of Columbus, Ohio. He lives with his supportive wife, Kendall, and a Miniature Schnauzer dog that he never wanted, but now can't imagine life without. To book Gabe for your next event or learn more about him, please visit gabehoward.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Vancouver city council will consider extending liquor serving hours to as late as 3 a.m. Joshua Davidson, director of operations at Downtown Van, joins the show to provide a business perspective, and Tim Naimi, director of the Canadian Institute of Substance Use Research, breaks down concerns. We ask viewers if they think later liquor hours should be implemented in their community.

They can fly by before you even hear them - those sleek two wheeled battery powered scooters. They are transforming city sidewalks, bike lanes and roads, often bypassing traffic jams and drawing riders with a quick zip to their destination. But beyond the breezy rides there's a growing concern. Emergency room doctors are sounding the alarm - injuries linked to e-scooters have surged 32% in just one year, according to the latest data from the Canadian Institute for Health Information. Head trauma, shattered bones, sudden emergency department visits from what seems like a quick, fun ride. Sales are booming, sidewalks are crowding, and city planners and politicians are scrambling to figure out where they belong. Our question: Are e-scooters revolutionizing your daily commute or are they an accident waiting to happen?

As electric scooters gain popularity, the Canadian Institute of Health Information reports a rise in related injuries. It found nearly 1,000 people were hospitalized from scooter or e-scooter incidents over the course of a year. HUB Cycling is offering courses on using e-scooters and road safety. Its executive director, Rose Gardner, joins the show as we ask viewers about their experiences with e-scooters.

C-5 summit in Gatineau could set the the tone of government-Indigenous relations — for the rest of Mark Carney's time as Prime Minister. Brazil's Congress passes bill that drastically weakens the country's environmental safeguards. Canada's largest federal public sector union disputes Pierre Poilievre's account of why he lost his riding in the last election. United States senate passes President Donald Trump's recessions package, paving way for cuts to foreign aid and public broadcasting. Wildfire evacuees in Manitoba waiting for when they can return home. New report by Canadian Institute for Health Information finds more Canadians getting hurt by e-scooters. "Pretty Little Baby" singer Connie Francis dies at 87.

In this episode of YourForest Podcast, host Matthew Kristoff is joined by Kelly Cooper, founder of the Free to Grow in Forestry initiative, and Greg Herringer, chair of the Canadian Institute of Forestry's DEI leadership team. Through honest and eye-opening conversation, they unpack why change is so difficult, highlighting deep-rooted resistance, fear of change, and power dynamics that hold progress back. Kelly shares her personal experience of being excluded from the very DEI work she was leading, while Greg reflects on how bias shows up in both personal and professional spaces.

What do young children really need to understand about numbers? And why do some students struggle so much with maths—even from the very beginning? In this insightful episode, I'm joined by Professor Daniel Ansari, a leading cognitive neuroscientist whose work has shaped how we understand early mathematical development. We explore what number sense actually is, why symbolic understanding is so important and how to build arithmetic fluency without creating anxiety. Daniel also unpacks key ideas around subitising, dyscalculia and the role of spatial reasoning in maths success. If you teach in the early years or support students who find maths difficult, this episode is packed with practical insights you can take straight into your classroom. Tune in for an evidence-based conversation that will empower you to better support every child's mathematical journey, fostering confidence, fluency and a genuine love for maths! Resources mentioned: The Maths Guarantee (Grattan Institute report) The Maths Guarantee: A guide for principals (Grattan Institute) Assisting Students Struggling with Math (a guide from the Institute of Education Sciences) McNeil, N. M., Jordan, N. C., Viegut, A. A., & Ansari, D. (2025). What the science of learning teaches us about arithmetic fluency. Psychological Science in the Public Interest, 26(1), 10-57. Times Tables Rock Stars Stanislas Dehaene's Number Sense Chalk and Talk podcast (by Anna Stokke) You can connect with Daniel: Twitter: @NumCogLab Linkedin You can connect with Brendan: Twitter/X: @learnwithmrlee Facebook: @learningwithmrlee Linkedin: @brendan-lee-kft Website: learnwithlee.net   Support the Knowledge for Teachers Podcast:  https://www.patreon.com/KnowledgeforTeachersPodcast About Professor Daniel Ansari Daniel Ansari is a Professor and Canada Research Chair in Developmental Cognitive Neuroscience & Learning at Western University. Ansari and his team in the Numerical Cognition Laboratory explore how children develop numerical and mathematical skills and why some children struggle to acquire mathematical skills and knowledge. Ansari and his team are committed to bridging between the Science of Learning and K-12 Classrooms. Ansari is a Fellow of the Canadian Institute of Advanced Research (CIFAR).  

Made in China, sailed in B.C.? (0:46) B.C. Ferries faces public pressure over its recent decision to award a multi-billion-dollar contract to build four new major vessels to a Chinese shipyard Guest: Richard Zussman, Global B.C. Legislative reporter EV availability update (11:56) Clean Energy Canada's recommendations to the federal government's plans to update its ZEV mandate Guest: Rachel Doran, Executive Director of Clean Energy Canada Is this the route to energy security or Environmental trouble? (22:18) Guest: Ellis Ross - Member of Parliament representing Skeena-Bulkley Valley in British Columbia Teachers vs. Tate: Who's shaping young minds? (34:00) Guest: Luc Cousineau - co-director of research at the Canadian Institute for Far-Right Studies and faculty at Dalhousie University in Halifax Learn more about your ad choices. Visit megaphone.fm/adchoices

In Episode 118, Patrick welcomes back returning guest Prineha Narang, professor at UCLA and a leader at the intersection of quantum science and materials engineering.They explore the accelerating trajectory of Quantum Computing, including the rising private venture interest, and how hybrid approaches are advancing both materials science and energy efficiency. From distributed quantum sensor networks to diverse quantum architectures, the conversation highlights how interdisciplinary expertise is driving innovation across the field.Dr. Narang is a Professor in Physical Sciences and Electrical and Computer Engineering at UCLA with an interdisciplinary group spanning areas of physics, chemistry, and engineering. Prior to moving to UCLA, she was an Assistant Professor of Computational Materials Science at Harvard University. Before starting on the Harvard faculty in 2017, Dr. Narang was an Environmental Fellow at HUCE, and worked as a research scholar in condensed matter theory in the Department of Physics at MIT. She received an M.S. and Ph.D. in Applied Physics from Caltech. Her group works on theoretical and computational quantum materials, non-equilibrium dynamics, and quantum information science. Narang's work has been recognized by many awards and special designations, Narang's work has been recognized by many awards and special designations, including the 2023 Guggenheim Fellowship in Physics, Maria Goeppert Mayer Award from the American Physical Society, 2023 ONR Young Investigator Award, 2022 Outstanding Early Career Investigator Award from the Materials Research Society, Mildred Dresselhaus Prize, Bessel Research Award from the Alexander von Humboldt Foundation, a Max Planck Sabbatical Award from the Max Planck Society, and the IUPAP Young Scientist Prize in Computational Physics all in 2021, an NSF CAREER Award in 2020, being named a Moore Inventor Fellow by the Gordon and Betty Moore Foundation, CIFAR Azrieli Global Scholar by the Canadian Institute for Advanced Research, a Top Innovator by MIT Tech Review (MIT TR35), and a leading young scientist by the World Economic Forum in 2018.In 2017, Dr. Narang was named by Forbes Magazine on their “30under30” list for her work in atom-by-atom quantum engineering, that is, designing materials at the smallest scale, using single atoms, to enable the leap to quantum technologies. Dr. Narang has held leadership roles in a DOE EFRC ‘Photonics at Thermodynamic Limits', DOE NQI Quantum Science Center, and the NSF ERC ‘Center for Quantum Networks', among others. Her continued service to the science community includes chairing the Gordon Conference on Ultrafast and Cooperative Phenomena, Materials Research Society (MRS) Spring Meeting (2022) and the MRS-Kavli Foundation Future of Materials Workshop: Computational Materials Science (2021), organizing APS, Optica (OSA), and SPIE symposia, and a leadership role in APS' Division of Materials Physics. Narang is an Associate Editor at ACS Nano of the American Chemical Society, an Associate Editor at Applied Physics Letters of the American Institute of Physics, and the Editorial Advisory Boards of Nano Letters and Advanced Photonics. 

AiArthritis is bringing you along for the journey as part of our Go With Us! Program, this time straight from the EULAR 2025 in Barcelona. In this episode, we're spotlighting key research updates that matter most to patients living with AiArthritis diseases. Our 'co hosts, Leila, Tiffany, Deb, and Eileen, are on the ground at EULAR, reporting back with fresh insights into patient-prioritized topics. You'll hear how nutrition and microbiome research is shifting how we understand inflammation and autoimmune risk, why CAR T-cell therapy is creating buzz as a potential path to long-term remission, and what new research is saying about enthesitis in spondyloarthritis. Plus, learn more about the debate on the pros and cons of cannabis use for chronic pain management. This episode brings the conference experience straight to you with a focus on what it all means for real patients.   Donate to Support the Show: www.aiarthritis.org/donate   Episode Highlights: Insights from new research linking diet and gut health to autoimmune activity What CAR T-cell therapy could mean for the future of treatment A deeper look at enthesitis and how it's being understood in spondyloarthritis How the medical community is reevaluating the use of cannabis in treatment plans.   Links & Resources Go With Us! To EULAR 2025 YouTube Playlist: https://www.youtube.com/playlist?list=PLZW5ZyvNnYl3wsrI7usV495JH2OMfUdzN Have questions about this episode or topics you want to hear us bring to the table? Email us at podcast@aiarthritis.org  Follow AiArthritis on all social media platforms @IFAiArthritis Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE   Connect with our Co Hosts:   Leila is the Health Education Manager at the International Foundation for AiArthritis. She is a person living with Lupus and Sjögren's disease. She is passionate about inclusion and diversity in health education and meeting individuals where they are at in order to learn in a way that resonates with them.   Eileen Davidson is a rheumatoid arthritis patient advocate from Vancouver Canada. She volunteers with the Arthritis Research Canada patient advisory board and the Canadian Institute of Health Research - Institute of Musculoskeletal Health and Arthritis patient engagement research ambassador, among others. When not advocating she is writing about her experience with arthritis through Creaky Joints, Healthline, Chronic Eileen or can be found being a mom to her son Jacob.   Tiffany Westrich-Robertson is the CEO at AiArthritis (International Foundation for Autoimmune & Autoinflammatory Arthritis) and uses her professional expertise in mind-mapping and problem solving to help others, like her, who live with AiArthritis diseases work in unison to identify and solve unresolved community issues.   Deb Constien is a medically retired Registered Dietitian and a Representative for AiArthritis with Rheumatoid Arthritis. Deb is also on the Advisory Council for WREN- Wisconsin Research Education Network and a Patient Family Advisor- PFA on an International PCORI research study for ACP- Advanced Care Planning.

Nathalie BajosSanté publique (2024-2025)Collège de FranceAnnée 2024-2025Colloque - La production sociale des inégalités de santé : approches théoriques et données empiriques. Perspectives internationalesSession 3 : Interroger la structuration sociale des inégalités de santé en anthropologie et en épidémiologieGreta Bauer : A New Framework for Understanding Social Privilege and HealthGreta BauerProfessor and Director, Eli Coleman Institute for Sexual and Gender Health, University of Minnesota Medical SchoolRésuméWhile health research has increasingly included a role for stigma and discrimination in impacting health, privilege is often left to be implicitly understood as a lack of these. This undertheorization of privilege limits our understanding of how social power shapes health. I present a seven-fold model of privilege and its intersectional formation. Privilege is conceptualized as taking seven forms: just and fair experience, allowed harmful ignorance, promotion and facilitation, implicitly understood meaning, respect for autonomy and bodily integrity, successful moves to innocence, and assumed good intentions. Each form can be enacted through interpersonal or structural mechanisms. While this seven-fold model can be applied to individual conceptualizations of privilege (e.g., heterosexual privilege, white privilege), an intersectionality framework is key to understanding how power and privilege differentials operate relationally to affect health. Intersectionality helps explain, for example, why the traditional socioeconomic gradient of health has differential returns for people of different races, gender expressions, and disabilities, or why a generally privileged position such as maleness may not present an advantage when considered in relation to other social positions and contexts. I provide a set of thinking tools for incorporating this seven-fold and intersectional understanding of privilege into public health work.Greta BauerGreta Bauer, PhD, MPH is a Professor and Director of the Eli Coleman Institute for Sexual and Gender Health in the University of Minnesota Medical School. She holds the endowed academic chair in sexual health. Prior to 2022, Dr. Bauer was a Professor in the Department of Epidemiology and Biostatistics in the Schulich School of Medicine & Dentistry at Western University in London, Canada, where she held a Sex and Gender Science Chair through the Canadian Institutes of Health Research (CIHR). Dr. Bauer has authored more than 150 peer-reviewed papers, book chapters, and technical reports related to health equity. As an epidemiologist, her focus on sexual and gender health has been both substantive and methodological, with a focus on the impacts of social marginalization. She is a leader in transgender and non-binary health, and in incorporating intersectionality into quantitative research methods.

Even in the name of love, we can justify hatred, even murder, of the other. But why do we hate others? Scholars have identified a list of 10 reasons why one group may hate another group. They also have suggestions on how to break the cycle of hate. Guests in this episode are scholars from the Canadian Institute for Advanced Research (CIFAR):Prerna Singh, professor of political science, Brown University, U.S.Victoria Esses, professor of psychology, Western University, London, Ontario Stephen Reicher, professor of social psychology, University of St. Andrews, Scotland

Following the COVID-19 pandemic, wait times for critical surgeries continue to rise. And Saskatchewan continues to rank near the bottom nationally when it comes to joint replacement surgeries. Anne Atkinson, project lead in health system analytics for the Canadian Institute for Health Information (CIHI), joins Evan to break down the data and how this impacts how you receive health care.

Jerry opens the show by talking about a bike lane advocacy group who said more bikes than cars travelled along Bloor during rush hour. Brian Lilley joins Jerry to talk about Canada's EV mandates. The federal government says it will move open baking forward at the 'earliest opportunity,' Preet Banerjee explains what this means. Canada will adjust metal counter tariffs against the US on July 21, Keanin Loomis, the president and CEO if the Canadian Institute of Steel Construction weighs in on how the industry is feeling.

Chinese Steel is making a mess of the Patullo Bridge Guest: Keanin Loomis, President and CEO Canadian Institute of Steel Construction Learn more about your ad choices. Visit megaphone.fm/adchoices

Chinese Steel is making a mess of the Patullo Bridge Guest: Keanin Loomis, President and CEO Canadian Institute of Steel Construction How are BC wineries handling tariffs and trade disputes? Guest: Jeff Guinard, CEO, WINE Growers of British Columbia Why are adults giving up on friendships? Guest:  Laura Eramian, Associate Prof. Department of Sociology and Social Anthropology, Dalhousie University Is AI already taking entry level jobs? Guest: Shabnam Ivkovic, Director of Co-operative and experiential education, Waterloo Why is North Vancouver booting RV's off the streets Guest: Herman Mah, District of North Vancouver City Councillor Does being high eliminate accountability? Guest: Angela Marie Macdougal, Executive Director, Battered Women Support Service. Learn more about your ad choices. Visit megaphone.fm/adchoices

With new evidence emerging about the impact of connection on health, social prescribing is bridging the gap between clinical care and community care.Dr. Kate Mulligan is a health geographer, an assistant professor at the University of Toronto, and the scientific director at the Canadian Institute for Social Prescribing. This special episode of The Conversation Piece features content from her presentation at The Walrus Talks at Home: Rx Belonging, supported by The Belonging Forum, an initiative of the Samuel Centre for Social Connectedness.Dr. Mulligan spoke at The Walrus Talks at Home: Rx Belonging on September 25, 2024.To register for upcoming events happening online or in a city near you, and to catch up on our archive of The Walrus Talks, visit thewalrus.ca/events.And subscribe to The Walrus Events newsletter for updates and announcements at thewalrus.ca/newsletters. Hosted on Acast. See acast.com/privacy for more information.

Send us a textListen as Dr. Bernie Pauly describes her research projects over time, making change with people on the margins. She discusses how she got there, what motivates her and how the teams she worked with made it happen. Dr. Bernie Pauly is a Professor in the School of Nursing, a Scientist with the Canadian Institute for Substance Use Research and a University of Victoria Community Engaged Scholar. Her research focuses on the promotion of health equity at the intersection of substance use and homelessness in collaboration with communities impacted by health inequities. Her research has informed provincial, regional, and national harm reduction policies in nursing, housing and healthcare including National Operational Guidance for Managed Alcohol Programs. She is a fellow of the Canadian Academy of Nursing and Canadian Academy of Health Sciences and an international collaborator with Salvation Army Centre for Addictions Services and Research at the University of Stirling (Scotland) and the Australian MAP Protocol Steering Committee. For her work and contributions, she has received numerous awards including the Canadian Public Health Association Ron Draper Health Promotion Award, Nurse and Nurse Practitioner Association of BC: Excellence in Advancing Nursing Knowledge and Research Award, a BC Reconciliation Award and BC Community Achievement Award and Phillip Owen Award for Excellence in Policy Research.Instagram: @calling.all.nursesComments and feedback can be sent to our email: callingallnurses.podcast@gmail.com

Today on The Brian Crombie Hour, Brian interviews Christopher Coates. Lt.-Gen. (Ret'd) Christopher Coates is director of national defence and foreign policy at the Macdonald-Laurier Institute. His contributions to the Canadian Institute for Arctic Security are informed by a 34-year military career in which he served in senior leadership roles alongside Canada's allies and defence partners, including NATO, the United Nations, and NORAD. Christopher talks about Donald Trump's proposed Golden Dome. 

In this episode, Dr Tsen Vei Lim talks to Dr James MacKillop, a clinical psychologist and professor at McMaster University in Canada, and director for both the Peter Boris Centre for Addictions Research and the Michael G DeGroote Centre for Medicinal Cannabis Research. The interview covers his research report on the diagnostic validity of drinking behaviour for identifying alcohol use disorder (AUD) with findings from a representative sample of community adults and an inpatient clinical sample. · What alcohol use disorder is and how it is currently diagnosed [01:41]· The surprising exclusion of drinking behaviour in AUD diagnosis [03:03]· Unpacking ‘receiver operating characteristic curves' [04:42]· The key findings of the study [05:45]· Whether James' findings will change how we think about diagnosing AUD [07:35]· Why clinicians would benefit collecting how much people are drinking in one session [09:32]· Whether an indicator of heavy drinking would be helpful in treatment settings [10:35]· Bringing objective data into clinical application [12:09]· Whether we can use a similar metric to other drugs, such as cannabis [13:09]· What we can learn for policy and further research [15:56]· The barrier of the lack of biomarkers in alcohol use disorder [18:00]· The take-home message of the paper [19:40]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the SSA, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK). About James MacKillop PhD, CPsych, FCAHS: Dr. MacKillop holds the Peter Boris Chair in Addictions Research and a Canada Research Chair in Translational Addiction Research at McMaster University and St. Joseph's Healthcare Hamilton. There, Dr. MacKillop directs both the Peter Boris Centre for Addictions Research and the DeGroote Centre for Medicinal Cannabis Research. Dr. MacKillop trained as a clinical psychologist at Binghamton University and Brown University and studies addiction using a multidisciplinary approach, integrating psychology, economics, neuroscience, and genetics. James receives unrestricted research funding from Canadian Institutes on Health Research, the National Institutes of Health, and Correctional Services of Canada and am a senior scientist and principal in Beam Diagnostics, Inc., a technology transfer start-up company. The latter had no relationship to the publication in Addiction.Original article: Diagnostic validity of drinking behaviour for identifying alcohol use disorder: Findings from a representative sample of community adults and an inpatient clinical sample. https://doi.org/10.1111/add.70037The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal. The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

https://vimeo.com/1079953899?share=copy When we are inundated with the shadows and the dense frequencies of the human consciousness and the unconscious and that's all we're seeing is that shadow coming up into the light.  We might forget who we are.  We might get lost in that shadow and start to get mired in it. How do we break free? How do we transmute, alchemize, bring love to everything we're witnessing?  Today we have John Stringer with us, who is a life teacher, a song writer, a healer, and brings so many gifts to the world.  I invite you to join us as we have a conversation about navigating these times with love! John Stringer began receiving direct from Source / Spirit on-demand (aka channeling) in 2008.  John Stringer has written and recorded several albums (including a co-written top 10 best-selling Billboard chart hit single) and has performed throughout the world. His music has been featured on major network television and he has also appeared in national print ads. John Stringer speaks publicly, writes music & lyrics; serves others in group, remote & one-on-one channeling sessions; and writes content for his websites and books to share the teachings he continues to receive. Watch or listen to the show for practical tips on how to break from the shadow and navigate these times with love. You're Invited! CHECK OUT: Unlock Your Songwriting Challenge https://www.johnstringerinc.com/5-day-uysgc-grad-offer/ LISTEN: Awakened Pillow Talk Podcast https://www.healingartsmgmt.com/podcasts/   JOHN STRINGER BIO John is a life teacher, speaker, Billboard-charting singer-songwriter, healer, and award-winning International Bestselling author. He currently serves as Founder of PolyPlat Records, Partner at Healing Arts Management , Founder of ConsciousSongwriting.com, Partner at ConsciousSongwritingRetreat.com, Co-host of Awakened Pillow Talk podcast, host of The Alignment Podcast, Co-Founder of MasterMomentMakers.com, and he served as a True Collaboration℠ leader at BandingPeopleTogether.com. He now travels extensively, speaking and sharing his uplifting and healing music and message through songs from both his debut solo album, “Limitless Love & Light,” which features the 2017 Posi Award-nominated song, “That's Love;”  and his follow up album, “Moment to Moment;” along with channeled teachings found in his book, The Abundance Vibration: A Guide to Alignment and his most recent award-winning, international bestselling book, the INside effects: How the Body Heals Itself, Volume 2. His music is currently being used for the theme songs at the Canadian Institute for Natural Integrative Medicine, Life University, the City of Hapeville, Special Needs Certified, Orlando Pranic Healing Centers and other wonderful organizations spreading love in their own way. Between enjoying his wonderful wife and children in Atlanta, GA, John continues sharing his life and following where Source leads. Life's Goal: To be Limitless Love & Light from Moment to Moment LINKS Web: https://www.johnstringerinc.com/ Podcast: https://www.healingartsmgmt.com/podcasts/ Facebook: https://www.facebook.com/johnstringer1111/ Instagram: https://www.instagram.com/john.h.stringer/ LinkedIn: https://www.linkedin.com/in/jstringer/ YouTube: https://www.youtube.com/user/JohnHStringer   YOUR GUIDE TO SOUL NECTAR: KERRI HUMMINGBIRD I love mentoring women to rewrite the story of their lives through inner transformation, connection to essence, remembrance of purpose, and realignment to authenticity and truth. If you don't want to settle for anything less than a life of passion and purpose, book a Discovery Call and let's talk! Schedule today! http://bit.ly/2CpFHFZ FREE GIFT: The Love Mastery Game, an oracle for revealing your soul's curriculum in every day challenges. http://www.kerrihummingbird.com/play JOIN SOUL NECTAR TRIBE! https://kerrihummingbird.com/membership

The Anabaptists, alongside the Lutheran and Reformed churches, were the third major current in the sixteenth century Reformation movements. From their beginnings, the Anabaptists were highly diverse and yet they shared some central beliefs and practices for which they were quickly persecuted – for example, defenselessness and nonresistance, the refusal to swear oaths, and the separation of church and state. Ideal for both teachers and students, this book provides a comprehensive and scholarly account of the history and development of the Anabaptists, alongside the Mennonite, Hutterite, and Amish traditions that emerged from their movement. Anabaptists: From the Reformation to the 21st Century (Pandora Press, 2024) shows the cultural diversity of the Anabaptists over five centuries as they moved between persecution and toleration, isolation and social integration, and traditionalization and renewal. Amidst these tensions, the Anabaptist story is told here anew based on the current state of the field on the eve of its 500-year anniversary. Written by an established scholar of Anabaptist history, and expertly translated into English by Victor Thiessen, this comprehensive study appears in the Anabaptist and Mennonite Studies series, edited by Maxwell Kennel, and published by Pandora Press. Maxwell Kennel is Senior Research Fellow with the Canadian Institute for Far-Right Studies (CIFRS), Director of Pandora Press, and Pastor at the Hamilton Mennonite Church. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Anabaptists, alongside the Lutheran and Reformed churches, were the third major current in the sixteenth century Reformation movements. From their beginnings, the Anabaptists were highly diverse and yet they shared some central beliefs and practices for which they were quickly persecuted – for example, defenselessness and nonresistance, the refusal to swear oaths, and the separation of church and state. Ideal for both teachers and students, this book provides a comprehensive and scholarly account of the history and development of the Anabaptists, alongside the Mennonite, Hutterite, and Amish traditions that emerged from their movement. Anabaptists: From the Reformation to the 21st Century (Pandora Press, 2024) shows the cultural diversity of the Anabaptists over five centuries as they moved between persecution and toleration, isolation and social integration, and traditionalization and renewal. Amidst these tensions, the Anabaptist story is told here anew based on the current state of the field on the eve of its 500-year anniversary. Written by an established scholar of Anabaptist history, and expertly translated into English by Victor Thiessen, this comprehensive study appears in the Anabaptist and Mennonite Studies series, edited by Maxwell Kennel, and published by Pandora Press. Maxwell Kennel is Senior Research Fellow with the Canadian Institute for Far-Right Studies (CIFRS), Director of Pandora Press, and Pastor at the Hamilton Mennonite Church. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Anabaptists, alongside the Lutheran and Reformed churches, were the third major current in the sixteenth century Reformation movements. From their beginnings, the Anabaptists were highly diverse and yet they shared some central beliefs and practices for which they were quickly persecuted – for example, defenselessness and nonresistance, the refusal to swear oaths, and the separation of church and state. Ideal for both teachers and students, this book provides a comprehensive and scholarly account of the history and development of the Anabaptists, alongside the Mennonite, Hutterite, and Amish traditions that emerged from their movement. Anabaptists: From the Reformation to the 21st Century (Pandora Press, 2024) shows the cultural diversity of the Anabaptists over five centuries as they moved between persecution and toleration, isolation and social integration, and traditionalization and renewal. Amidst these tensions, the Anabaptist story is told here anew based on the current state of the field on the eve of its 500-year anniversary. Written by an established scholar of Anabaptist history, and expertly translated into English by Victor Thiessen, this comprehensive study appears in the Anabaptist and Mennonite Studies series, edited by Maxwell Kennel, and published by Pandora Press. Maxwell Kennel is Senior Research Fellow with the Canadian Institute for Far-Right Studies (CIFRS), Director of Pandora Press, and Pastor at the Hamilton Mennonite Church. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

The Anabaptists, alongside the Lutheran and Reformed churches, were the third major current in the sixteenth century Reformation movements. From their beginnings, the Anabaptists were highly diverse and yet they shared some central beliefs and practices for which they were quickly persecuted – for example, defenselessness and nonresistance, the refusal to swear oaths, and the separation of church and state. Ideal for both teachers and students, this book provides a comprehensive and scholarly account of the history and development of the Anabaptists, alongside the Mennonite, Hutterite, and Amish traditions that emerged from their movement. Anabaptists: From the Reformation to the 21st Century (Pandora Press, 2024) shows the cultural diversity of the Anabaptists over five centuries as they moved between persecution and toleration, isolation and social integration, and traditionalization and renewal. Amidst these tensions, the Anabaptist story is told here anew based on the current state of the field on the eve of its 500-year anniversary. Written by an established scholar of Anabaptist history, and expertly translated into English by Victor Thiessen, this comprehensive study appears in the Anabaptist and Mennonite Studies series, edited by Maxwell Kennel, and published by Pandora Press. Maxwell Kennel is Senior Research Fellow with the Canadian Institute for Far-Right Studies (CIFRS), Director of Pandora Press, and Pastor at the Hamilton Mennonite Church. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/german-studies

The Anabaptists, alongside the Lutheran and Reformed churches, were the third major current in the sixteenth century Reformation movements. From their beginnings, the Anabaptists were highly diverse and yet they shared some central beliefs and practices for which they were quickly persecuted – for example, defenselessness and nonresistance, the refusal to swear oaths, and the separation of church and state. Ideal for both teachers and students, this book provides a comprehensive and scholarly account of the history and development of the Anabaptists, alongside the Mennonite, Hutterite, and Amish traditions that emerged from their movement. Anabaptists: From the Reformation to the 21st Century (Pandora Press, 2024) shows the cultural diversity of the Anabaptists over five centuries as they moved between persecution and toleration, isolation and social integration, and traditionalization and renewal. Amidst these tensions, the Anabaptist story is told here anew based on the current state of the field on the eve of its 500-year anniversary. Written by an established scholar of Anabaptist history, and expertly translated into English by Victor Thiessen, this comprehensive study appears in the Anabaptist and Mennonite Studies series, edited by Maxwell Kennel, and published by Pandora Press. Maxwell Kennel is Senior Research Fellow with the Canadian Institute for Far-Right Studies (CIFRS), Director of Pandora Press, and Pastor at the Hamilton Mennonite Church. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/religion

The Anabaptists, alongside the Lutheran and Reformed churches, were the third major current in the sixteenth century Reformation movements. From their beginnings, the Anabaptists were highly diverse and yet they shared some central beliefs and practices for which they were quickly persecuted – for example, defenselessness and nonresistance, the refusal to swear oaths, and the separation of church and state. Ideal for both teachers and students, this book provides a comprehensive and scholarly account of the history and development of the Anabaptists, alongside the Mennonite, Hutterite, and Amish traditions that emerged from their movement. Anabaptists: From the Reformation to the 21st Century (Pandora Press, 2024) shows the cultural diversity of the Anabaptists over five centuries as they moved between persecution and toleration, isolation and social integration, and traditionalization and renewal. Amidst these tensions, the Anabaptist story is told here anew based on the current state of the field on the eve of its 500-year anniversary. Written by an established scholar of Anabaptist history, and expertly translated into English by Victor Thiessen, this comprehensive study appears in the Anabaptist and Mennonite Studies series, edited by Maxwell Kennel, and published by Pandora Press. Maxwell Kennel is Senior Research Fellow with the Canadian Institute for Far-Right Studies (CIFRS), Director of Pandora Press, and Pastor at the Hamilton Mennonite Church. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/christian-studies

Listen to today's podcast... Part of spring cleaning is tackling your cupboards and drawers.  Well how about that medicine cupboard? Do You Know About Medication Safety? I know that mine had been neglected when I found a jar of Vicks medicated rub from when I was a kid.  Yes, that was a long time ago and yes, it was about time that it was thrown out.  I have no idea if that stuff ever goes bad, but I probably should have thrown it out years ago.  I have carted it from my bedroom, to my residence room, to my first apartment, and then from one home to the next with my family. Medication errors are said to affect at least 1.5 million Canadians per year according to the Canadian Institute for Health Information.  And those mistakes can be disastrous. Medication safety isn't just about an expiry date.  It's about safe storage.  Knowing what medications may interact with other medications, food and supplements. It's about telling your doctor about any side effects you may have had from previous prescriptions and what supplements or over-the-counter medications you may be taking. Take One Action Today To Build Your #Resiliency!      Here are today's Tips For Building Resiliency and Celebrating Medication Safety Week: Check your prescriptions periodically for expiration dates Don't share medicines with friends or family Dispose of medications properly. Most pharmacies will take your old drugs for proper disposal. Avoid putting them in trashcans or into the toilet Remember that the term “natural” does not necessarily mean “safe”.  Treat all supplements and herbal remedies with the same respect as you would any prescribed medications  Make Sure That Your Family Stays Safe And Healthy Want to find more strategies to coping with stress? Check out my website at worksmartlivesmart.com #mentalhealth #hr

Dr. Amato is a biological anthropologist studying the influence of gut microbes on host ecology and evolution. Her research examines how changes in the gut microbiota impact host nutrition, energetics, and health. She uses non-human primates as models for studying host-gut microbe interactions in selective environments and for providing comparative insight into the evolution of the human gut microbiota. Her main foci are understanding how the gut microbiome may buffer hosts during periods of nutritional stress and how the gut microbiome programs normal inter-specific differences in host metabolism. In this realm, she is also interested in global variation in the human gut microbiome and its implications for local human adaptation. Dr. Amato obtained her A.B. in Biology from Dartmouth College and her Ph.D. in Ecology, Evolution and Conservation Biology from the University of Illinois at Urbana-Champaign. She completed a postdoc at the University of Colorado Boulder. She joined the Department of Anthropology in 2015. She is also affiliated with the Interdisciplinary Biological Sciences Graduate Program and sits on the Executive Committee of the Northwestern Institute on Complex Systems. Dr. Amato is the President of the Midwest Primate Interest Group, an Associate Editor at Microbiome, an Editorial Board member at Folia Primatologica, and a Fellow for the Canadian Institute of Advanced Research's ‘Humans and the Microbiome' Program. ------------------------------ Find the paper discussed in this episode: Mallott, E., Kuthyar, S., Lee, W., … & Amato, K. R. (2024). The primate gut microbiota contributes to interspecific differences in host metabolism. Microbial genomics, https://doi.org/10.1099/mgen.0.001322 ------------------------------ Contact the Sausage of Science Podcast and Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Chris Lynn, Co-Host. Website: cdlynn.people.ua.edu/, E-mail: cdlynn@ua.edu, Twitter:@Chris_Ly Cristina Gildee, Guest Co-Host, HBA Junior Fellow, SoS producer. Website: cristinagildee.org, E-mail: cgildee@uw.edu, Twitter:@CristinaGildee Anahi Ruderman, SoS Co-Producer, HBA Junior Fellow. E-mail: aniruderman@gmail.com, Twitter: @ani_ruderman

In our first episode, Jennifer is joined by Ranj Pillai, Premier of Yukon, for a conversation about what it means to build economic resilience in the North. Premier Pillai speaks about Yukon's response to global tensions and economic uncertainty, emphasizing infrastructure investment to support major investments in critical mineral projects. He underscores the importance of long-term planning, strong partnerships with Indigenous peoples and maintaining Arctic sovereignty. And, with Yukon's economy performing well, he also highlights the creation of the Canadian Institute for Arctic Security to counter foreign interference and strengthen defence in the North.

In this episode, CIAJ's Articling Student David Lazzam sits down with Jessyca Greenwood, Principal Lawyer at Greenwood Law, to discuss how the legal system responds to substance dependency in the workplace. Drawing from years of experience representing vulnerable clients, Jessyca explores common legal challenges, gaps in employer obligations, and the role of stigma in shaping outcomes. Together, they examine how specialized courts and diversion programs can help—or hinder—real change. From courtroom culture to systemic reform, this conversation highlights the need for compassion, accountability, and broader social supports to ensure that people struggling with addiction aren't left behind.   Guest Jessyca Greenwood, Principal Lawyer at Greenwood Law (Toronto, ON) Host David Lazzam, Articling Student at the Canadian Institute for the Administration of Justice (Ottawa, ON)

I'm thrilled to announce that our next guest on The Mixtape with Scott is Professor Philip Oreopoulos—one of the most impactful economists working today in education and labor. A PhD student advisee of David Card, Phil is part of the distinguished lineage that helped shape the credibility revolution in applied microeconomics.Now a Professor of Economics and Public Policy at the University of Toronto, Phil has spent his career studying how education policies and interventions affect outcomes for students and workers. His work blends rigorous causal inference with real-world relevance to uncover how both the very large interventions we employ to help society, as well as the seemingly surgically narrow ones, shape the lives of workers and students. He's also a Research Associate at the National Bureau of Economic Research and a Research Fellow at the Canadian Institute for Advanced Research. His CV is full of important papers, but it's the heart behind the work that really stands out—his curiosity about the world and his desire to make a difference. In this episode, we go beyond the papers. We talk about his journey, what it was like working with David Card, and how he found his calling. It's a thoughtful, warm conversation with a scholar who represents the very best of what economics can be.Scott's Mixtape Substack is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Get full access to Scott's Mixtape Substack at causalinf.substack.com/subscribe

Send us a textA new CMAJ study has found that alcohol-related hospitalizations and deaths in Canada surged during the COVID-19 pandemic. While overall alcohol consumption increased only modestly, the toll on the healthcare system was severe, with a 14% rise in hospitalizations and a 24% increase in deaths during the first two years of the pandemic. Researchers suggest that increased access to alcohol—through expanded retail hours and home delivery—contributed to these harms, particularly among heavier drinkers.Dr. Tim Stockwell, a scientist at the Canadian Institute for Substance Use Research and an emeritus professor at the University of Victoria, discusses the study's findings and why even a small rise in alcohol consumption can lead to a disproportionate increase in harm. He explains how heavier drinkers, already at risk, were pushed beyond critical health thresholds, contributing to the sharp rise in hospitalizations and deaths.Dr. Adam Sherk, a senior scientist at the Canadian Centre on Substance Use and Addiction, examines the policy decisions that shaped alcohol access during the pandemic. While economic considerations played a role, he notes that governments were also reluctant to introduce new restrictions on alcohol at a time when the public was already under significant strain. He argues that a more balanced approach is needed in future public health crises—one that allows reasonable access to alcohol but uses measures like increased pricing and decreased availability to moderate its impact on the healthcare system.The findings underscore the need to rethink how alcohol policy is handled during public health emergencies—not just in terms of balancing health and economic interests, but also in managing public willingness to accept restrictions in times of crisis.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X @BlairBigham and @DrmojolaomoleX (in English): @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Read the full transcript here. How were decisions made about which treatments to trust before the advent of "evidence-based" medicine? How strong are biological arguments for or against various treatments? When did the Evidence-Based Medicine (EBM) movement begin? How did the EBM movement overcome initial resistance among medical professionals? What resources do doctors have at their disposals to find up-to-date information about treatment efficacies? Why is the pharmaceutical industry allowed such influence over information about treatments? What is the GRADE approach to EBM? What does EBM have to say about the role of patient preferences and values? How bad is being overweight? What are "surrogate" or "substitute" outcomes? How rigorous is the Diagnostic and Statistical Manual of Mental Disorders (DSM)? How often do treatments suffer from a lack of high-quality evidence of an effect versus plenty of high-quality evidence of a lack of an effect? What's the state of evidence about the placebo effect? What are the most exciting current initiatives in EBM?Gordon Guyatt is a McMaster University Distinguished Professor. His work has focused on Evidence-Based Medicine and promoting high-quality healthcare without financial barriers for all Canadians. His Order of Canada citation acknowledges both contributions. He has been honored as a Canadian Institute of Health Research Researcher of the Year and a member of the Canadian Medical Hall of Fame. Learn more about Gordon and his work at clarityresearch.ca.Further reading"This is why you shouldn't believe that exciting new medical study" by Julia Belluz @ Vox StaffSpencer Greenberg — Host / DirectorJosh Castle — ProducerRyan Kessler — Audio EngineerUri Bram — FactotumWeAmplify — TranscriptionistsMusicBroke for FreeJosh WoodwardLee RosevereQuiet Music for Tiny Robotswowamusiczapsplat.comAffiliatesClearer ThinkingGuidedTrackMind EasePositlyUpLift[Read more]

Brilliant minds, global challenges, collaborative solutions – these are the power of the Canadian Institute for Advanced Research (CIFAR). In this episode, Douglas Nelson speaks with their President and CEO Stephen Toope who unveils how CIFAR is breaking down research silos to tackle the world's most complex problems, one brilliant collaboration at a time. He shares their approach to bringing together top researchers, fostering long-term partnerships, and empowering early-career researchers to pursue transformative knowledge. Dive into the innovative discoveries happening at CIFAR, from quantum physics to AI safety, and learn why advanced research is more critical than ever.

Parenting is challenging, but adding a chronic illness like rheumatoid arthritis brings unique obstacles. In this episode, co-host Eileen shares her journey of raising a child while managing RA, from coping with fatigue and pain to adjusting expectations. She's joined by her 12-year-old son, Jacob, who offers his perspective on growing up with a parent who has a chronic illness. Together, they discuss the struggles, unexpected lessons, and ways they support each other. Whether you're a parent navigating chronic illness or looking to understand its impact on families, this episode offers insight, advice, and encouragement. Donate to Support the Show: www.aiarthritis.org/donate Episode Highlights: Eileen shares her journey of parenting with RA, from early diagnosis to raising a preteen. The biggest struggles of parenting with chronic illness, including fatigue, guilt, and daily challenges. Jacob's perspective on having a parent with RA and how it has shaped his life. The unexpected positives—how chronic illness has taught Jacob responsibility, independence, and empathy. Practical tips for parents with chronic illness, including self-care, communication, and asking for help. Links & Resources Volunteer with AiArthritis : https://bit.ly/AiArthritisVolunteerApp   Connect with our Cohost: Eileen Davidson is a rheumatoid arthritis patient advocate from Vancouver Canada. She volunteers with the Arthritis Research Canada patient advisory board and the Canadian Institute of Health Research - Institute of Musculoskeletal Health and Arthritis patient engagement research ambassador, among others. When not advocating she is writing about her experience with arthritis through Creaky Joints, Healthline, Chronic Eileen or can be found being a mom to her son Jacob.   Connect with Eileen: Twitter: @ChronicEileen   Follow AiArthritis on all social media platforms @IFAiArthritis Sign up for our Monthly AiArthritis Voices 360 Talk Show newsletter! HERE    

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Olivier Drouin from the University of Montreal, Canada. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Dr Olivier Drouin. Dr Olivier Drouin is a Clinical Assistant Professor in both the Department of Paediatrics and Department of Social and Preventive Medicine at Université de Montréal. In the February podcast Olivier Drouin discusses his ongoing pilot randomized trial of a brief digital screening and intervention tool for parental and adolescents to address tobacco and electronic cigarette use, CanCEASE. This study takes place in paediatric medical care settings in Canada and is funded by the Canadian Institutes of Health Research. Their pilot study aims to demonstrate the feasibility and evaluate the preliminary effectiveness of the CEASE program for parental smoking cessation and its adapted version for adolescent smoking cessation and adolescent and parental vaping cessation. There is a strong need for effective and cost-effective smoking and vaping cessation interventions for parents and adolescents. If successful, this study will help inform the preparation of a fully powered randomized controlled trial of CEASE in Canada in these populations. Olivier Drouin discusses the importance of behavioural science in understanding the drivers of behaviour and health behaviour change, including the use of scientific method to understand rational and irrational behaviours, habit formation and the role of peer pressure and social norms. The pilot study discussed in this podcast by Chadi at al 2023 is DOI: https://dx.doi.org/10.2196/47978; NCT05366790. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Our literature searches for the EC for smoking cessation review carried out on 1st February 2025 found 2 new studies (Ikonomidis 2024 DOI: 10.1093/eurheartj/ehae666.3388; Kouroutzoglou 2024 DOI: 10.1093/eurheartj/ehae666.2955) and 6 papers linked to studies included in our review. Our catch-up search for our interventions for quitting vaping review up to 1st February 2025 found 7 new ongoing studies and 4 linked papers. For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub9/full For more information on the full Cochrane review of Interventions for quitting vaping published in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub2/full This podcast is supported by Cancer Research UK.

On this episode, Emily Kircher-Morris and Dr. Daniel Ansari discuss the complexities of math education, including the anxiety it can cause in students, the challenges of teaching methods, and the importance of understanding learning difficulties like dyscalculia. They talk about the importance of explicit instruction in math, the role of neuroscience in understanding how children learn math, and the significance of working memory and attention in math learning. Educators and parents will also get suggestions for practical strategies that will help them support students struggling with math. TAKEAWAYS Math anxiety affects both children and adults. Explicit instruction is crucial for teaching math. Dyscalculia is often misunderstood and underrecognized. Teaching methods should align with children's developmental levels. Neuroscience reveals links between spatial and numerical processing. Math anxiety does not equate to a lack of ability. Timed practice should be engaging, not competitive. Working memory plays a significant role in math learning. Multisensory approaches can enhance math instruction. Parents should seek community and resources for support. Assisting Students Struggling with Mathematics from the Institute of Education Sciences The Think Inclusive Podcast episode Emily talked about - Saving ED: Why the U.S. Department of Education is Essential for Students with Disabilities This episode is sponsored by The Council for Exceptional Children, getting ready for their Convention & Expo in Baltimore, March 12-15th. Go to cecconvention.org to register! Dr. Daniel Ansari is a Professor and Canada Research Chair in Developmental Cognitive Neuroscience & Learning at Western University. He leads the Numerical Cognition Laboratory, where his research focuses on how children develop numerical and mathematical skills, as well as the cognitive factors contributing to difficulties in learning mathematics. Dr. Ansari and his team are dedicated to bridging the Science of Learning with K-12 education, working to translate research findings into classroom practice. He has authored over 150 peer-reviewed research articles and is a Fellow of the Canadian Institute for Advanced Research (CIFAR), recognized for his contributions to the field of developmental cognitive neuroscience. BACKGROUND READING The Numerical Cognition Laboratory The Neurodiversity Podcast is available on Facebook, Instagram, BlueSky, and you can also join our private Facebook group.

Somia Sadiq is an award-winning entrepreneur and peacebuilder who has developed a pioneering practice in impact assessment and conflict transformation rooted in storytelling. Somia is the founder and CEO of Narratives, a planning firm that emphasizes human-centric, trauma-informed dialogue, lived experience, and celebrating ancestral identity. She's also the founder of Kahanee, a non-profit organization that works nationally and internationally interweaving stories to support peacebuilding efforts. Somia is a published author and a keynote speaker, offering insights on trauma-informed leadership, and fostering resilience in a rapidly changing environment. Recognized for her contributions to the Planning practice in Canada and globally, Somia was recently inducted into the Canadian Institute of Planners' esteemed College of Fellows, the highest honor for a planner in Canada. Her new book Garajah will be published in August 2025.

Dr. Michael Muthukrishna, Associate Professor at LSE, joins Alan to explore his book, A Theory of Everyone. It reveals how cultural evolution—our “software” of beliefs, language, and logic—shaped humanity's unique trajectory. He explains the "laws" of energy and innovation: energy abundance fuels cooperation and progress, while innovations like the steam engine drive efficiency and competition. Michael highlights the "paradox of diversity," where fresh ideas thrive amid aligned communication and norms. He links societal challenges like division and inequality to resource scarcity and calls for leveraging technologies like AI and startup cities to foster collaboration, sustainable innovation, and global progress.     Guest Bio Dr. Michael Muthukrishna is an Associate Professor of Psychological and Behavioral Science at the London School of Economics, with a unique academic foundation in software engineering and psychology from the University of Queensland, and advanced degrees from the University of British Columbia. He has held prestigious roles at Harvard, Yale, and the Canadian Institute for Advanced Research. Recognized for his groundbreaking work, Michael has received accolades like the 2024 Excellence in Quantitative Methods Research Award and a John Templeton Foundation grant. He is the author of the acclaimed book, A Theory of Everyone, which redefines how we understand human evolution and progress.       Show Highlights (2:24) What A Theory of Everyone entails (12:14) The fundamental “law” of energy (20:31) The “law” of innovation (22:47) COMPASS - the seven secrets of innovation (26:22) The paradox of diversity (30:20) How humans' big heads have affected our evolution (38:11) The next level of human cultural evolution (46:25) The necessary steps to the next stage of tying societies back together (52:10) How to protect the engine of growth amidst negative circumstances (54:23) What's next for Michael Muthukrisha     Links Referenced A Theory of Everyone: The New Science of Who We Are, How We Got Here, and Where We're Going: https://www.amazon.com/Theory-Everyone-Science-where-Going/dp/026204837X

For the regular drinker, the studies that say a daily tipple is better for a longer life than avoiding alcohol completely are a source of great comfort. But a new analysis challenges that thinking and says it was based on flawed research that compares drinkers with people who are sick and sober. In this episode from August, Madeleine Finlay hears from the study's lead author, Tim Stockwell, a scientist at the Canadian Institute for Substance Use Research at the University of Victoria, to find out why scientists (including him) were so convinced, and what the actual risks of alcohol are. Help support our independent journalism at theguardian.com/sciencepod

We have long heard the claims that a glass of red wine is good for your heart, but it turns out that the research that fueled this wisdom was actually skewed. Some studies made it appear like moderate drinkers were healthier than people who didn't drink at all, leading the public to believe that alcohol was healthier than it is. While drinking alcohol occasionally might not have catastrophic effects on your health, the data shows that even moderate drinking will reduce your life expectancy.In this episode, we speak with Tim Stockwell, a scientist at the Canadian Institute for Substance Use Research and a professor of psychology at the University of Victoria. Stockwell has reviewed hundreds of studies that he claims embellished alcohol's effects, and he explains how the new science of drinking is changing the public perception of alcohol. Today, trends like sober-curiosity and “Dry January” are on the rise, and some countries around the world are even implementing new policies around alcohol regulation.

On this episode, we are joined by Ben Mortenson and Janet Craik, both occupational therapists in Canada who have done extensive work on sustainability in healthcare. They share with us the pillars of sustainability and how we as therapists can do our part to ensure economic, social and environmental sustainability. Guest Bios: Janet Craik holds a Bachelor of Science degree in occupational therapy from Queen's University and a Master's degree in Rehabilitation Science from the University of Toronto. Her involvement as an occupational therapist includes many years as a front-line practitioner, manager, author, educator, and former Executive Director for the Canadian Association of Occupational Therapists. She is deeply interested in exploring how to improve health systems in Canada to be more sustainable. As an instructor at the University of Toronto, she is involved with an interprofessional education elective on climate change and teaches an elective on sustainable health in occupational therapy to ensure students have knowledge and resources needed to identify climate change-related risks and take equitable, evidence-based action to promote health, well-being, and occupational participation. In addition to instructing at the University of Toronto, she is the Rehabilitation Lead for CASCADES (www.cascadescanada.ca) and the Executive Director for the International Cognitive Approaches Network (www.icancoop.org).Ben Mortenson has been an occupational therapist since 1991. He is Professor and Head of the Department of Occupational Science and Occupational Therapy at the University of British Columbia. He held a New Investigator Award from the Canadian Institutes of Health Research (2016-2021). He is a principal investigator at the GF Strong Rehabilitation Research Program and International Collaboration on Repair Discoveries. He is an experienced mixed-methods researcher with over 200 peer-reviewed publications and he has over $7M in funding as a principal investigator or co-PI and almost $50M as co-investigator. He has had over 300, peer reviewed abstracts accepted at national and international conferences. He has provided research supervision to over 130 trainees. His work is centered on four main populations: assistive technology users, informal and formal caregivers, individuals with spinal cord injury, and residents in long-term care. His research focuses on four overlapping areas: assistive technology, social participation, accessibility and sustainability. He was the 2021 recipient of the Award for Innovative Practice from the Canadian Association of Occupational Therapy (CAOT). In 2022 he was inducted as a CAOT Fellow.

EPISODE #1102 ESTABLISHING DIPLOMATIC RELATIONS WITH ET Richard welcomes the Co-Founder of The Alliance for Extraterrestrial Diplomatic Contact (or AEDC) to discuss best practices for establishing diplomatic relations with extraterrestrials. GUEST: Sylvain Rochon is an international speaker, futurist, author, scientist, engineer and serial entrepreneur with a passion for progress. His focus in life is to learn as much as possible about the universe and to elevate humanity to its next level of society where no one needs to worry about survival, and where everyone can reach self-enlightenment. He is a professional futurist, having published articles in several online magazines including Church and State, 10th, Floor Living, Institute of Directors, Special Noise, Becoming Human, EcoEnclose, Data Driven Investor, The Startup, Digital Trends and TechTarget. He has also published a non-fiction book entitled, “Engineering Paradise: Are You Ready?” in 2018 illustrating how we could build the world we need to sustain all peoples. As a serial entrepreneur, he is co-founder of media tech companies Canadian Institute of Mass Communication, CykoMetrix, the think tank Intellectua and the Alliance for Extraterrestrial Diplomatic Contact. WEBSITE: https://alliance4et.org BOOKS: Engineering Paradise: Are You Ready? SUPPORT OUR SPONSORS!!! HIMS - Making Healthy and Happy Easy to Achieve Sexual Health, Hair Loss, Mental Health, Weight Management START YOUR FREE ONLINE VISIT TODAY - HIMS dot com slash STRANGE https://www.HIMS.com/strange BECOME A PREMIUM SUBSCRIBER!!! https://strangeplanet.supportingcast.fm Three monthly subscriptions to choose from. Commercial Free Listening, Bonus Episodes and a Subscription to my monthly newsletter, InnerSanctum. We and our partners use cookies to personalize your experience, to show you ads based on your interests, and for measurement and analytics purposes. By using our website and services, you agree to our use of cookies as described in our Cookie Policy. Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://strangeplanet.supportingcast.fm/

For years, people felt good drinking a glass or two of red wine for the supposed health benefits, but last year the World Health Organization declared that “no level of alcohol consumption is safe for our health.” The debate over alcohol and health is happening as the federal government prepares to release new dietary and nutrition guidelines next year. We'll talk to experts about whether light drinking is harmful and what we can expect from the new guidelines. And we want to hear from you, how much alcohol do you deem safe? Guests: Esther Mobley, senior wine critic, San Francisco Chronicle Dr. Gregory Marcus, cardiologist, electrophysiologist and professor of medicine, University of California, San Francisco Adam Sherk, scientist, Canadian Institute for Substance Use Research at the University of Victoria - He is also a researcher for the World Health Organization's Collaborating Centre for Alcohol and Public Health Policy.